InnoSer Midbrain Organoids Webinar

15 October 2020 | 16:00
with OrganoTherapeutics co-founder & CSO Javier Jarazo

WHAT IS IT ABOUT?

A platform for Parkinson’s disease drug development

In-vivo like in-vitro environment

Derived from healthy or patient human cells, midbrain organoids make a 3D drug screening platform for Parkinson’s Disease, providing results that cannot readily be replicated in 2D cultures.

Javier Jarazo

OrganoTherapeutics

The webinar will include a scientific presentation by Javier Jarazo, co-founder and CSO of our partner company OrganoTherapeutics, which is is a spin-off project from the University of Luxembourg.

Drug development

InnoSer offers midbrain organoid platform as a service for Parkinson’s drug development. With our scientific expertise and state-of-the-art facilities, we provide you fast and reliable results.

SIGN UP HERE

Your place at this webinar is just a few clicks away!

Our event is free of charge. However, we do have limited places availble. So please use the sign up form here to register for the webinar. You can scroll down within the embedded window and easily fill out the form.

At the end of the event, we will reserve time for your questions but you can always feel free to direct your questions to our business development manager Pascal Simoëns via the contact info below.

We look forward to welcoming you to our event!

InnoSer offers innovative in-vitro and in-vivo research services.

You can also stay up to date with important developments at InnoSer and engage with us at our social platforms as well.

Having trouble with Captcha?

  • Visit registration page in a new window.
  • Reach out via the contact form below to register manually. We are happy to help!
  • Sign in and use the Zoom App or Web SDK to avoid any issues.

Talk to InnoSer’s BDM Pascal

“I am happy to talk to you about our midbrain organoid platform and discuss how InnoSer services can be customized for your projects.”

plsimoens@innoserlaboratories.com

(+32) 460957428

8am-5pm